Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Profile of Daughters and Sisters of Women With Polycystic Ovary Syndrome: The Role of Proband's Glucose Tolerance
Indexado
WoS WOS:000756897900024
Scopus SCOPUS_ID:85124850825
DOI 10.1210/CLINEM/DGAB812
Año 2022
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



Context First-degree relatives of women with polycystic ovary syndrome (PCOS) present hormonal and metabolic alterations compared to girls unrelated to PCOS. It is unknown whether glucose intolerance in the PCOS proband confers a more severe metabolic predisposition on their first-degree relatives. Objective To determine whether glucose tolerance status in women with PCOS is associated with worsened glucose metabolism and sex hormone levels in their peripubertal daughters or sisters. Design Cross-sectional study. Setting Seven academic centers in North America, South America, and Europe. Patients Sixty-four pairs of women with PCOS and their daughters or younger sisters aged between 8 and 14 years were recruited. Twenty-five mothers or older sisters with PCOS were glucose intolerant (GI) and 39 were normal glucose tolerant (NGT). Main Outcome Measures Beta-cell function estimated by the insulin secretion-sensitivity index-2 (ISSI-2) during an oral glucose tolerance test and by the disposition index during a frequently sampled IV glucose tolerance test. Free testosterone and 17-hydroxyprogesterone (17-OHP) levels. Results Being related to a GI PCOS proband was associated with a lower ISSI-2 (P-value = 0.032) after adjusting for ethnicity, body mass index z-score, and pubertal stage. They also had higher free testosterone (P-value = 0.011) and 17-OHP levels compared to girls with an NGT proband, the latter becoming significant after adjusting for confounders (P-value = 0.040). Conclusions Compared to first-degree female relatives of women with PCOS and NGT, first-degree relatives of women with PCOS and GI display lower beta-cell function and hyperandrogenemia, putting them at higher risk of GI and PCOS development.

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Endocrinology & Metabolism
Scopus
Endocrinology, Diabetes And Metabolism
Biochemistry
Clinical Biochemistry
Biochemistry (Medical)
Endocrinology
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Harnois-Leblanc, Soren - CHU Sherbrooke - Canadá
UNIV MONTREAL - Canadá
Centre Hospitalier Universitaire de Sherbrooke - Canadá
University of Montreal - Canadá
Université de Sherbrooke - Canadá
2 HERNANDEZ-CARDENAS, MARIA ISABEL Mujer UNIV MONTREAL - Canadá
Universidad de Chile - Chile
University of Montreal - Canadá
3 CODNER-DUJOVNE, ETHEL Mujer Universidad de Chile - Chile
4 CASSORLA-GOLUBOFF, FERNANDO JAVIER Hombre Universidad de Chile - Chile
5 Oberfield, Sharon E. Mujer Columbia Univ - Estados Unidos
Columbia University Irving Medical Center - Estados Unidos
6 Leibel, Natasha Mujer Columbia Univ - Estados Unidos
Columbia University Irving Medical Center - Estados Unidos
7 Mathew, R. - Vanderbilt Univ - Estados Unidos
Vanderbilt University School of Medicine - Estados Unidos
8 Ten, Svetlana Mujer Richmond Univ - Estados Unidos
Richmond University Medical Center - Estados Unidos
9 Magoffin, Denis A. Hombre Cedars Sinai Med Ctr - Estados Unidos
Cedars-Sinai Medical Center - Estados Unidos
10 Lane, Christianne J. Mujer Univ Southern Calif - Estados Unidos
Keck School of Medicine of USC - Estados Unidos
11 Goran, Michael Hombre Univ Southern Calif - Estados Unidos
Keck School of Medicine of USC - Estados Unidos
12 Azziz, R. Hombre Univ Alabama Birmingham - Estados Unidos
SUNY Albany - Estados Unidos
University of Alabama at Birmingham School of Medicine - Estados Unidos
School of Public Health - Estados Unidos
Heersink School of Medicine - Estados Unidos
13 Baillargeon, Jean-Patrice Hombre CHU Sherbrooke - Canadá
Univ Sherbrooke - Canadá
Centre Hospitalier Universitaire de Sherbrooke - Canadá
Université de Sherbrooke - Canadá
14 Geller, David H. Hombre Univ Southern Calif - Estados Unidos
Childrens Hosp Los Angeles - Estados Unidos
Keck School of Medicine of USC - Estados Unidos
Children's Hospital Los Angeles - Estados Unidos

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
FONDECYT
National Institute of Child Health and Human Development
National Institute of Diabetes and Digestive and Kidney Diseases
National Center for Research Resources
NIH grant National Institute of Child Health and Human Development (NICHD)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (National Center for Research Resources [NCRR])
Fonds de Recherche du Quebec-Sante PhD Award for Health Professionals
Helping Hand of Los Angeles, Inc.
NIH grant National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Department of Medicine award at Universite de Sherbrooke
individual Clinical Research Feasibility Fund award
Fonds de Recherche du QuebecSante Senior Investigator Award
Faculty of Medicine and Health Sciences at Universite de Sherbrooke Graduate award

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
This study was supported by NIH grants National Institute of Child Health and Human Development (NICHD) K23 1HD40325 (to D.H.G.), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) RO1 59211 (to M.I.G.), M01-RR00425 (to R.A.), MO1-RR00425 (General Clinical Research Center Grant from the National Center for Research Resources [NCRR]), and Fondecyt Grant 1170895 (to E.C.). S.H-L. was supported by Faculty of Medicine and Health Sciences at Universite de Sherbrooke Graduate award and is currently supported by Fonds de Recherche du Quebec-Sante PhD Award for Health Professionals. R.A. is supported by an endowment from the Helping Hand of Los Angeles, Inc. J-P.B. is supported by Fonds de Recherche du QuebecSante Senior Investigator Award and a Department of Medicine award at Universite de Sherbrooke. D.H.G. is supported by an individual Clinical Research Feasibility Fund award.

Muestra la fuente de financiamiento declarada en la publicación.